# PURPOSE 1 Trial: 100% HIV Prevention in Women

**ID:** TRT-002
**Year:** 2024
**Source:** Gilead
**Link:** [https://www.prepwatch.org/products/lenacapavir-for-prep/](https://www.prepwatch.org/products/lenacapavir-for-prep/)

---

## Abstract

Landmark trial showing zero HIV infections among 2,134 women receiving twice-yearly lenacapavir in Africa.

---

## Key Concepts

- Primary research focus from 2023-2025 HIV literature
- Relevant to understanding HIV biology, treatment, or prevention
- Contributes to the broader HIV research landscape

---

## Relevance to Project

This paper contributes to the Ternary VAE bioinformatics project by providing context on:
- HIV sequence evolution and variability
- Biological constraints on viral fitness
- Therapeutic targets and resistance mechanisms

---

*Added: 2025-12-24*
